Arena grants newco Everest Chinese rights to candidates

Arena Pharmaceuticals Inc. (NASDAQ:ARNA) granted Everest Medicines Ltd. (Boston, Mass.) exclusive rights to develop and commercialize ralinepag (APD811) and etrasimod

Read the full 204 word article

User Sign In